Skip to main content
TOOLS
The Morningstar Fund Compare tool quickly evaluates different funds against one another. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
The Morningstar Portfolio Review tool compares and analyzes your portfolio holdings. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
utility-drawer__mobile-restriction Tools are currently unavailable for use on mobile. Please visit the desktop site.
fund compare tool image
Fund Compare
Quickly evaluate different MFs, CEFs and ETFs against one another
portfolio review tool image
Portfolio Review
Generate a detailed analysis of your portfolio holdings including MFs, CEFs and ETFs
Image of Municipal bond investing ladder tool
Municipal Bond Ladder Tool
Learn how a laddered portfolio may perform in rising rate environments
Powered by Morning star
Welcome to Nuveen
Select your preferred site so we can tailor your experience.
Select Region...
  • Americas
  • Asia Pacific
  • Europe, Middle East, Africa
location select
Select Location...
  • Canada
  • Latin America
  • United States
  • Australia
  • Hong Kong
  • Japan
  • Mainland China
  • Malaysia
  • New Zealand
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Other
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Ireland
  • Italy
  • Luxembourg
  • Middle East
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • Other
location select
Global Cities REIT (GCREIT)
  • Institutional Investor
  • Individual Investor
  • Financial Professional
  • Global Cities REIT (GCREIT)
  • Green Capital
  • Private Capital Income Fund (PCAP)
location select
background-Locust Grove Physician Center

Locust Grove Physician Center

Locust grove aerial view

Locust Grove Physician Center is a newly-constructed 40,000 square foot outpatient medical office, which is 100% leased to a credit worthy tenant. The building is a Class A purpose-built medical office which will provide limited capital expenditure over the hold period.

As a 100% leased building to investment grade tenancy with over 6.5 years of term and 2.5% annual rent escalations, the property is well positioned for growth.

Located at the highly visible I-75 / Bill Garner Parkway interchange, the property is well positioned at the midway point of travel between Atlanta and Macon. As growth continues to move south from Atlanta and north from Macon, the key growth areas are converging in Locust Grove. Within a 10-mile radius of the subject property, the population is expected to grow at roughly 1.25 times that of the overall Atlanta MSA.

The high-quality, healthcare-system-anchored asset profile is consistent with our investment thesis of capturing the demand tailwind for outpatient facilities that provide affordable and convenient access to ambulatory outpatient medicine, versus high-cost inpatient care.

 
Richard Kimble, Portfolio Manager


Further information
  • Atlanta is well positioned for fiscal recovery from COVID largely due to its strong net migration rate for 2020, low projected unemployment rate, low concentration of small business employment, and its relatively stable fiscal outlook.
  • The global headquarters of 15 Fortune 500 companies are in Atlanta, including Coca-Cola, The Home Depot, and Delta Air Lines.
  • Emory University and Georgia Tech comprise more than 41,000 undergraduate and graduate students, giving a large student presence in Atlanta.
  • High-tech employment in Atlanta grew at least 3% per year from 2011-2016.
  • 38% of the population has achieved a bachelor’s, graduate, or professional degree.
  • Hartsfield-Jackson Atlanta International Airport has served more than 100 million passengers per year since 2015.

Featured content

These properties represent select holdings at the time of publication and are not meant to represent the entire portfolio. The opinions expressed are reflective of the manager's views at the time of acquisition.

Contact us
Contact us
Back to Top